Bluestar Adisseo, an animal nutrition company and one of the largest producers of the poultry protein methionine, aims to raise around $1.5 billion in a Hong Kong-Paris dual initial public offering listing, according to reports.
Adisseo plans to list itself on the markets in Hong Kong and Paris in September, with hopes of attracting European investors, reports say.
In July, Adisseo began the first formal step in the Hong Kong listing process through an A1 filing. Following the filing, the Hong Kong stock exchange will hold a hearing to approve Adisseo’s listing and allow the company to hold informal meetings to gauge the interest of potential investors.
Reports say Adisseo’s listing deal is being handled by Morgan Stanley, Deutsche Bank AG, CCB International (Holdings) Ltd., BOC International Holdings Ltd., Credit Suisse Group and Goldman Sachs Group.
